BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18626511)

  • 21. Regulation of p63 function by Mdm2 and MdmX.
    Kadakia M; Slader C; Berberich SJ
    DNA Cell Biol; 2001 Jun; 20(6):321-30. PubMed ID: 11445003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p63: the phantom of the tumor suppressor.
    Finlan LE; Hupp TR
    Cell Cycle; 2007 May; 6(9):1062-71. PubMed ID: 17426453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p53-homologue p63 may promote thyroid cancer progression.
    Malaguarnera R; Mandarino A; Mazzon E; Vella V; Gangemi P; Vancheri C; Vigneri P; Aloisi A; Vigneri R; Frasca F
    Endocr Relat Cancer; 2005 Dec; 12(4):953-71. PubMed ID: 16322335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
    Shimada A; Kato S; Enjo K; Osada M; Ikawa Y; Kohno K; Obinata M; Kanamaru R; Ikawa S; Ishioka C
    Cancer Res; 1999 Jun; 59(12):2781-6. PubMed ID: 10383130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene.
    Sbisà E; Mastropasqua G; Lefkimmiatis K; Caratozzolo MF; D'Erchia AM; Tullo A
    Cell Cycle; 2006 Jan; 5(2):205-12. PubMed ID: 16410722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner.
    Yan W; Chen X
    J Biol Chem; 2006 Mar; 281(12):7856-62. PubMed ID: 16446369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 Family isoforms.
    Bourdon JC
    Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C terminus of p53 family proteins is a cell fate determinant.
    Harms KL; Chen X
    Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism.
    Serber Z; Lai HC; Yang A; Ou HD; Sigal MS; Kelly AE; Darimont BD; Duijf PH; Van Bokhoven H; McKeon F; Dötsch V
    Mol Cell Biol; 2002 Dec; 22(24):8601-11. PubMed ID: 12446779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.
    Johnson J; Lagowski J; Lawson S; Liu Y; Kulesz-Martin M
    Oncogene; 2008 Apr; 27(19):2780-7. PubMed ID: 18026135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAp63γ demethylation regulates protein stability and cellular distribution during neural stem cell differentiation.
    Fonseca MB; Nunes AF; Morgado AL; Solá S; Rodrigues CM
    PLoS One; 2012; 7(12):e52417. PubMed ID: 23251711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 and p73 in human cancer: defining the network.
    Deyoung MP; Ellisen LW
    Oncogene; 2007 Aug; 26(36):5169-83. PubMed ID: 17334395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syntaxin 6, a regulator of the protein trafficking machinery and a target of the p53 family, is required for cell adhesion and survival.
    Zhang Y; Shu L; Chen X
    J Biol Chem; 2008 Nov; 283(45):30689-98. PubMed ID: 18779328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dominant-negative interplay between p53, p63 and p73: A family affair.
    Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
    Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization and expression of p63 isoforms in human keloids.
    De Felice B; Wilson RR; Nacca M; Ciarmiello LF; Pinelli C
    Mol Genet Genomics; 2004 Aug; 272(1):28-34. PubMed ID: 15248062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double dealing tale of p63: an oncogene or a tumor suppressor.
    Chen Y; Peng Y; Fan S; Li Y; Xiao ZX; Li C
    Cell Mol Life Sci; 2018 Mar; 75(6):965-973. PubMed ID: 28975366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
    Crook T; Nicholls JM; Brooks L; O'Nions J; Allday MJ
    Oncogene; 2000 Jul; 19(30):3439-44. PubMed ID: 10918601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.